ArticleJournal of experimental & clinical cancer research : CR2021

A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.

Wei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.